ADAR and cancer: They further demonstrated that LGP2 was essential for the T1-IFN response in cancer cells induced by concomitant ADAR1 loss and treatment with DNA methyltransferase inhibitors, the latter previously shown to induce MDA5 activation through sensing of de-repressed EREs (20, 21).